Torpedo Bio

Founders Leonardo Ferreira

About

Torpedo Bio is developing a genetically engineered immune cell therapy to target solid tumors. Early models show dose response and superiority over existing treatments.

Product Video

Pitch Video

Our Investment

Beemok Capital and InvestSC invested $125,000 each, totaling $250,000.